Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control
- 23 March 2010
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 100 (3), 221-228
- https://doi.org/10.1016/j.ymgme.2010.03.014
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Systemic hypertension in two patients with ASL deficiency: A result of nitric oxide deficiency?Molecular Genetics and Metabolism, 2009
- Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodesActa Paediatrica, 2008
- Cross-sectional multicenter study of patients with urea cycle disorders in the United StatesMolecular Genetics and Metabolism, 2008
- Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle DisordersNew England Journal of Medicine, 2007
- Clinical Consequences of Urea Cycle Enzyme Deficiencies and Potential Links to Arginine and Nitric Oxide MetabolismJournal of Nutrition, 2004
- NEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSDrug Metabolism and Disposition, 2004
- Urea Cycle Disorders: Diagnosis, Pathophysiology, and TherapyAdvances in Pediatrics, 1996
- Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiencyMetabolism, 1993
- Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen ExcretionPediatric Research, 1991